Based on our proprietary pharmaceutical R&D platform, we independently initiate and develop projects. Upon achieving phased R&D results, we engage in various collaboration models. Additionally, we have established an MAH (Marketing Authorization Holder) platform to support partners in product implementation or collaboration.